Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000278942 corresponds to AC004494.2 (TEC), which is listed as a novel transcript with no evidence of being a protein-coding gene or functional characterized target in major scientific databases[3]. There is no published data associating it with molecular functions, roles in disease, or therapeutic targeting. It is not annotated in gene-centric or therapeutic target databases, suggesting the entry may be a misidentification, pseudogene, or uncharacterized locus. Summary of findings: - This Ensembl gene ID (ENSG00000278942) is mapped to AC004494.2 (TEC) in the Broad Institute's reference, annotated simply as a transcript[3]. - No functional, biological, or disease-related information is available. - There are no known aliases beyond the automated gene prediction/annotation. - It does not feature in any prioritizations or reviews of receptors, enzymes, transporters, or established drugs targets[1][3]. - As such, there appears to be an error or misidentification if this is expected to be a well-characterized molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AC004494.2 (TEC).